Arintra

Arintra

Private
Austin, TexasHealthcare & Life Scienceshttps://arintra.com

Last Round

Series A

Aug 12, 2025

Est. Valuation

$100M

Total Funding Raised

$21.5M

Momentum Score

75 /100

Company Overview

Arintra is a technology company that provides a GenAI-native autonomous medical coding platform for healthcare providers. Founded in 2020 by Nitesh Shroff and Preeti Bhargava, the company aims to help health systems get paid accurately and efficiently by automating the conversion of patient charts into insurance claims with precise medical codes. The platform integrates with major Electronic Health Record (EHR) systems like Epic and Cerner to reduce undercoding, lower claim denials, and decrease administrative workload for practitioners. Arintra is backed by investors including Y Combinator and Peak XV Partners. The company is headquartered in Austin, Texas, and is expanding with a new office in the Bay Area.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Medical AI, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

autonomous medical codingmedical coding automationrevenue cycle managementRCM automationEHR integrationmedical billing AIclinical documentation improvementCDIdenial preventionhealthcare AICPT codingICD-10 codingGenAI for healthcareusage-based pricingEpic integrationhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arintra Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arintra Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AAug 12, 2025
SeedMar 13, 2024
AcceleratorJan 10, 2022

Key People

Founding team and executive leadership

Preeti Bhargava

Co-Founder And CTO

Founding Team

Nitesh Shroff

CEO And Co-founder

Founding Team

Arintra Investors

Notable investors and investment history

InvestorRounds
Peak XV PartnersSeed, Series A
FoundersX VenturesSeed
Counterpart VenturesSeries A
Y CombinatorAccelerator, Seed, Series A
Endeavor Health VenturesSeries A
Spider CapitalSeries A
TEN13Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2025

    Added Reid Physician Associates, Inc. as a customer.

  • Sep 2, 2025

    Added Heart & Vascular Care, Inc. as a customer.

Arintra Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arintra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arintra's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range116
Year Founded2020
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.